|
KPNA1 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.292600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.387200E-01 |
| Normal-vs-Stage2 |
8.598000E-01 |
| Normal-vs-Stage3 |
7.668800E-01 |
| Normal-vs-Stage4 |
7.526600E-01 |
| Stage1-vs-Stage2 |
4.175200E-01 |
| Stage1-vs-Stage3 |
6.545800E-01 |
| Stage1-vs-Stage4 |
7.594000E-01 |
| Stage2-vs-Stage3 |
6.726200E-01 |
| Stage2-vs-Stage4 |
6.563200E-01 |
| Stage3-vs-Stage4 |
9.688000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.304000E-01 |
| Normal-vs-AfricanAmerican |
4.694000E-02 |
| Normal-vs-Asian |
7.641200E-01 |
| Caucasian-vs-AfricanAmerican |
9.741800E-02 |
| Caucasian-vs-Asian |
4.141200E-01 |
| AfricanAmerican-vs-Asian |
3.961600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.297200E-01 |
| Normal-vs-Female |
4.267000E-01 |
| Male-vs-Female |
4.217600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.661600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.312200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.557200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.447600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.756200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.263000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.759600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.864200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.309600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.072000E-01 |
| Classical-VS-Follicular |
4.169300E-04 |
| Classical-VS-Other |
1.109640E-01 |
| Classical-VS-Normal |
1.666160E-01 |
| Tall-VS-Follicular |
1.063870E-02 |
| Tall-VS-Other |
7.841900E-02 |
| Tall-VS-Normal |
1.162570E-01 |
| Follicular-VS-Other |
7.058800E-01 |
| Follicular-VS-Normal |
1.842840E-01 |
| Other-VS-Normal |
2.480200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.290600E-01 |
| Normal-vs-N1 |
9.302400E-01 |
| N0-vs-N1 |
6.777200E-01 |
|
|
